The Dual Function of RhoGDI2 in Immunity and Cancer

被引：3
|
作者：
Tripathi, Mudrika [1 ]
Colige, Alain [1 ]
Deroanne, Christophe F. F. [1 ]
机构：
[1] Univ Liege, Lab Connect Tissues Biol, GIGA Canc, B-4000 Liege, Belgium
来源：
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2023年 / 24卷 / 04期
关键词：
RhoGDI2; 1; RhoGDI1; 2; Rho GTPases 3; cancer; 4; immunity; 5; GDP-DISSOCIATION INHIBITOR; LY-GDI; RHO-GTPASES; CELL-PROLIFERATION; BREAST-CANCER; EXPRESSION; INVASION; PROMOTES; MIGRATION; PROTEIN;
D O I：
10.3390/ijms24044015
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
RhoGDI2 is a guanine nucleotide dissociation inhibitor (GDI) specific for the Rho family of small GTPases. It is highly expressed in hematopoietic cells but is also present in a large array of other cell types. RhoGDI2 has been implicated in multiple human cancers and immunity regulation, where it can display a dual role. Despite its involvement in various biological processes, we still do not have a clear understanding of its mechanistic functions. This review sheds a light on the dual opposite role of RhoGDI2 in cancer, highlights its underappreciated role in immunity and proposes ways to explain its intricate regulatory functions.
引用
收藏
页数：19
相关论文
共 50 条
  • [41] Diallyl disulfide downregulating RhoGDI2 induces differentiation and inhibit invasion via the Rac1/Pak1/LIMK1 pathway in human leukemia HL-60 cells
    Tan, Hui
    Jiang, Yiling
    Chen, Guangqun
    Liu, Ran
    Ling, Hui
    Yi, Lan
    He, Jie
    Qi, Su
    ENVIRONMENTAL TOXICOLOGY, 2023, 38 (06) : 1063 - 1077
  • [42] Regulation of ROCK1/2 by long non-coding RNAs and circular RNAs in different cancer types
    Farooqi, Ammad Ahmad
    Zahid, Rabbia
    Naureen, Humaira
    Attar, Rukset
    Gazouli, Maria
    Berardi, Rossana
    Szelachowska, Jolanta
    Matkowski, Rafal
    Pawlak, Edyta
    ONCOLOGY LETTERS, 2022, 23 (05)
  • [43] Interferon Gamma Inhibits CXCL8-Induced Proliferation and Migration of Pancreatic Cancer BxPC-3 Cell Line via a RhoGDI2/Rac1/NF-κB Signaling Pathway
    Zhang, Mingjie
    Ding, Guoping
    Zhou, Liangjing
    Shen, Tao
    Xu, Xiaodong
    Zhao, Ting
    Jia, Shengnan
    Cao, LiPing
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2018, 38 (09) : 413 - 422
  • [44] RhoGDI signaling provides targets for cancer therapy
    Harding, Michael A.
    Theodorescu, Dan
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (07) : 1252 - 1259
  • [45] RhoGDIβ-induced hypertrophic growth in H9c2 cells is negatively regulated by ZAK
    Huang, Chih-Yang
    Yang, Li-Chiu
    Liu, Kuan-Yu
    Liao, Pao-Hsin
    Chou, Janet Ing-Yuh
    Chou, Ming-Yung
    Lin, Wei-Wen
    Yang, Jaw-Ji
    JOURNAL OF BIOMEDICAL SCIENCE, 2009, 16
  • [46] RhoGDI2 positively regulates the Rho GTPases activation in response to the β2 outside-in signaling in T cells adhesion and migration on ICAM-1
    Liu, Wenai
    Wang, Xuehao
    Wang, Shan
    Ba, Xueqing
    Xu, Tingshuang
    Wang, Xiaoguang
    Zeng, Xianlu
    JOURNAL OF LEUKOCYTE BIOLOGY, 2019, 106 (02) : 431 - 446
  • [47] Regulation of microRNAs function by circular RNAs in human cancer
    Han, Chao
    Seebacher, Nicole A.
    Hornicek, Francis J.
    Kan, Quancheng
    Duan, Zhenfeng
    ONCOTARGET, 2017, 8 (38) : 64622 - 64637
  • [48] Aging, Cancer and Immunity
    Hong, Hong
    Wang, Qi
    Li, Jing
    Liu, Hans
    Meng, Xin
    Zhang, Haiyan
    JOURNAL OF CANCER, 2019, 10 (13): : 3021 - 3027
  • [49] Dual role of microRNAs in cancer metastasis
    Alaee, Mahdi
    Kiyamehr, Pegah
    Maroufi, Faezeh
    Maali, Amirhosein
    Azad, Mehdi
    HUMAN GENE, 2023, 38
  • [50] PRNP is a pan-cancer prognostic and immunity-related to EMT in colorectal cancer
    Chen, Haifeng
    Du, Yao
    Kong, Zhiyuan
    Liao, Xinghe
    Li, Weiping
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2024, 12
12345